● At closeAs of Jul 3, 2026
Roche Holding AG
SWX: ROP✓$421.50CHF 338.30-0.94%
$335.52BMarket cap
20.90xP/E ratio
338.29KVolume (24h)
Upgrade to Plus for the interactive DCF model, valuation bands, and implied-price scenarios.
Upgrade to PlusPlus is $20/mo. Cancel anytime.
| Company | Market cap | P/E | P/S | EV/EBITDA | Div yield |
|---|---|---|---|---|---|
 Eli Lilly and CompanyLLY | $1.14T | 42.53x | 15.63x | 34.89x | 0.54% |
 Johnson & JohnsonJNJ | $633.20B | 29.29x | 6.34x | 19.25x | 2.06% |
 AbbVie Inc.ABBV | $461.26B | 123.28x | 7.07x | 30.00x | 2.68% |
 UnitedHealth Group IncorporatedUNH | $386.29B | 31.34x | 0.84x | 18.59x | 2.15% |
| $335.52B |
| 20.90x |
| 4.38x |
| 13.10x |
| 2.90% |
 Merck & Co., Inc.MRK | $319.89B | 36.07x | 4.84x | 19.22x | 2.62% |
 Novartis AGSWX: NOVN | $303.21B | 22.42x | 5.38x | 15.20x | 2.92% |